a developer of biopharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that IFRX and BEAM have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and BEAM's prices will move in lockstep.
Ticker / NAME | Correlation To IFRX | 1D Price Change % | ||
---|---|---|---|---|
IFRX | 100% | +0.98% | ||
BEAM - IFRX | 30% Poorly correlated | -3.72% | ||
NNVC - IFRX | 30% Poorly correlated | -3.76% | ||
OMER - IFRX | 30% Poorly correlated | +28.19% | ||
BLPH - IFRX | 29% Poorly correlated | +44.74% | ||
OMGA - IFRX | 28% Poorly correlated | -1.80% | ||
More |